Sign up USA
Proactive Investors - Run By Investors For Investors

VentriPoint Diagnostics exhibiting at globe's largest cardiovascular imaging conference

Last year, the get-together attracted over 3,200 attendees from 90 countries
VentriPoint Diagnostics exhibiting at globe's largest cardiovascular imaging conference
VentriPoint has developed a suite of applications for all major heart diseases and imaging modalities

Medtech firm VentriPoint Diagnostics Ltd (CVE:VPT) said it was exhibiting at the EuroEcho- Imaging 2017 conference in Portugal - the world’s largest cardiovascular imaging congress, sending shares higher.

Last year, it attracted over 3,200 attendees from 90 countries last year and is the place to meet.

VentriPoint has developed a suite of applications for all major heart diseases and imaging modalities, including congenital heart disease, left or right heart failure and normal hearts.

“The sales and marketing team is excited about introducing the new 4-chamber VMS heart analysis system to the leading cardiologists for the first time,” said Dr George Adams, the chief executive at Ventripoint. 

“This conference has always been an excellent way to engage customers and learn about their plans for expansion and upgrading their echocardiography services.”

 The conference in Lisbon runs from December 6 to 8.

Shares are up 10% at C$0.28 in Toronto.

View full VPT profile View Profile

VentriPoint Diagnostics Timeline

Related Articles

picture of addict
November 15 2017
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
1504120610_biotechLatest.jpg
October 23 2017
The company is poised for a milestone-rich period over the next year or so
Frosties Box
December 04 2017
The company is a pioneer in the human microbiome, which is essentially the bacteria that inhabits the gut and skin

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use